Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.04 USD | -2.06% | -12.57% | -36.29% |
05-10 | UBS Trims Price Target on Amicus Therapeutics to $19 From $20, Keeps Buy Rating | MT |
05-09 | Amicus Therapeutics' Q1 Net Loss Narrows, Net Product Sales Rise | MT |
- Stock Market
- Equities
- FOLD Stock
- News Amicus Therapeutics, Inc.